NAD+ IV infusions for anti-aging: celebrity hype vs. actual evidence

What's this video probably claiming?

Based on the caption and hashtag context, this video is likely positioning NAD+ IV infusions as a legitimate anti-aging and energy-boosting therapy, validated by celebrity adoption from names like Jennifer Aniston, Joe Rogan, and the Biebers. The framing is classic aspirational wellness content: if A-listers are doing it, and now it's accessible via a discount code, you should be doing it too. The hashtags point toward claims about cognitive enhancement and possible ADHD symptom support, which is a meaningful escalation beyond vague "energy" language. The creator is probably not making explicit medical claims, but the implied message is that NAD+ infusions deliver measurable anti-aging effects, better energy, and sharper cognition, and that IV delivery is meaningfully superior to oral supplementation. That last part is where things get scientifically complicated.

What does the science actually show?

NAD+ (nicotinamide adenine dinucleotide) does decline with age, and that decline is well-documented. Rajman et al. (2018, Cell Metabolism) confirmed NAD+ depletion is associated with mitochondrial dysfunction and several age-related conditions in animal models. But the jump from "NAD+ declines with age" to "IV NAD+ infusions reverse aging in humans" is a large one that the current evidence does not support cleanly. Conze et al. (2019, Scientific Reports) showed oral nicotinamide riboside (NR) at 1000mg/day raised whole blood NAD+ by roughly 2.7-fold over 8 weeks in healthy adults, suggesting oral routes do work. The clinical data on IV NAD+ specifically for anti-aging endpoints in humans is thin. Most published human trials are small, short-duration, and often industry-funded. There are no large randomized controlled trials demonstrating IV NAD+ extends lifespan, reverses skin aging, or improves cognition in healthy adults.

Where does the social media noise diverge from clinical reality?

The biggest divergence is on delivery method superiority. IV infusions are positioned as more potent and bioavailable than oral NAD+ precursors, and for acute NAD+ repletion in specific clinical contexts, that may be true. But for healthy adults seeking anti-aging effects, the clinical evidence does not establish that IV dosing produces meaningfully better outcomes than well-studied oral precursors like NR or NMN. Pencina et al. (2023, Nature Aging) found that NMN supplementation improved muscle insulin sensitivity in older adults with prediabetes, but that was oral, not IV. The ADHD hashtag is a red flag. There is essentially no peer-reviewed clinical evidence linking NAD+ infusions to ADHD symptom improvement in humans. Celebrity endorsement is also not a data point. None of the named celebrities have published biomarkers or outcomes. Their reported use tells us nothing about efficacy.

What should you actually know?

NAD+ precursor supplementation is a legitimate area of active research, and some early findings are genuinely interesting. But IV NAD+ infusions for anti-aging in otherwise healthy people are ahead of their evidence base by a considerable margin. Costs for IV NAD+ protocols can run $200 to $1,000 per session, and multi-session protocols are typical. That is real money for outcomes that have not been rigorously quantified in healthy human populations. Side effects from IV NAD+ infusions, including chest tightness, nausea, and flushing, are commonly reported and appear to be rate-dependent, meaning faster infusions cause more discomfort. If you are interested in NAD+ support, the honest clinical conversation starts with oral precursors at studied doses, not a celebrity-adjacent IV drip. A discount code does not change the evidence base. Anyone presenting this as established anti-aging medicine should be pressed for the human RCT data, because right now it is limited.